Partner Rob Masella (New York-Merger & Acquisitions), Co-Head of the Healthcare Industry Group, spoke on the “The Rapid Acceleration of MedTech” panel at the 5th Annual Nordic-American Life Science Conference.
The Rapid Acceleration of MedTech
MedTech’s role in patient care is increasingly important, and the sector has active clinical and commercial development, strong deal flow, and a robust public market. As healthcare delivery, connectivity, and remote monitoring become ever more crucial, medical technologies meaningfully contribute to improved patient access, care delivery efficiency, and monitoring, diagnosing, and treating patients. At the same time, COVID-related shifts in elective procedures have created significant challenges and opportunities for MedTech companies of all sizes.
How will global MedTech thrive through COVID and beyond into a new era of healthcare? We had a discussion with MedTech strategy and financial experts.